{"gene":"SOSTDC1","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":2004,"finding":"USAG-1/SOSTDC1 recombinant protein directly binds BMPs and antagonizes BMP-mediated induction of alkaline phosphatase in C2C12 cells; injection of USAG-1 mRNA into Xenopus embryos induces secondary axis formation and hyperdorsalization, establishing it as a BMP antagonist.","method":"Recombinant protein binding assay, alkaline phosphatase in vitro cell assay, Xenopus mRNA injection","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct biochemical binding assay and functional cell-based assay plus in vivo Xenopus validation in a single study, multiple orthogonal methods","pmids":["15020244"],"is_preprint":false},{"year":2005,"finding":"USAG-1/SOSTDC1 is the central negative regulator of BMP function in the kidney; USAG-1-null mice show enhanced phosphorylation of Smad proteins (BMP signaling) and are resistant to acute and chronic renal injury; neutralizing antibody against BMP-7 abolishes renoprotection in USAG-1-null mice, placing USAG-1 upstream of BMP-7 in renal injury signaling.","method":"Knockout mouse model, Smad phosphorylation assay, neutralizing antibody treatment in vivo","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined renal phenotype, Smad phosphorylation readout, antibody rescue experiment confirming BMP-7 dependence; replicated across acute and chronic models","pmids":["16341262"],"is_preprint":false},{"year":2007,"finding":"USAG-1/SOSTDC1 is localized in distal renal tubules overlapping with BMP-7 expression; its expression ratio to BMP-7 increases dramatically during later kidney development and after renal regeneration, consistent with its role as the BMP-7 regulatory counterpart in kidney.","method":"Immunohistochemistry, in situ hybridization, expression analysis during kidney development and injury models","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization by immunohistochemistry replicated across developmental and injury contexts, functional link inferred from prior KO studies","pmids":["17943079"],"is_preprint":false},{"year":2007,"finding":"USAG-1/SOSTDC1 is expressed in the epithelium and mesenchyme of the rudimentary maxillary incisor and its abrogation rescues apoptotic elimination of odontogenic mesenchymal cells, leading to supernumerary tooth formation; USAG-1 controls tooth number by regulating apoptosis in this region.","method":"Knockout mouse model, localization by in situ hybridization/immunohistochemistry, apoptosis assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined cellular phenotype (apoptosis rescue, supernumerary teeth), localization confirmed; single lab","pmids":["17555714"],"is_preprint":false},{"year":2008,"finding":"In USAG-1/SOSTDC1-null mice, BMP signaling (assessed by Msx1, Dlx2 expression and Smad phosphorylation) is significantly enhanced in the rudimentary maxillary incisor; Wnt signaling (nuclear β-catenin) is also upregulated; inhibition of BMP signaling in explant culture rescues supernumerary tooth formation, demonstrating that enhanced BMP signaling drives the supernumerary tooth phenotype downstream of USAG-1 loss.","method":"Knockout mouse model, Smad phosphorylation assay, β-catenin nuclear localization, BMP inhibitor rescue in explant culture","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple signaling readouts plus pharmacological rescue experiment in organ culture; single lab but multiple orthogonal methods","pmids":["18329379"],"is_preprint":false},{"year":2009,"finding":"SOSTDC1 expressed in dental mesenchyme limits supernumerary incisor induction; reducing mesenchymal tissue around tooth germs in vitro phenocopies the Sostdc1-null extra incisor; both Noggin and Dkk1 individually prevent extra incisor formation, demonstrating that inhibition of both BMP and Wnt signaling contribute to the inhibitory role of dental mesenchyme.","method":"Sostdc1-null mouse model, in vitro organ culture with tissue reduction, Noggin and Dkk1 treatment rescue experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genetic KO combined with in vitro rescue with pathway-specific inhibitors; multiple orthogonal approaches in single study","pmids":["19141669"],"is_preprint":false},{"year":2010,"finding":"SOSTDC1/Wise inhibits Lrp5- and Lrp6-dependent Wnt signaling in tooth development; genetic reduction of Lrp5 and Lrp6 dosage rescues the Wise-null tooth phenotypes (supernumerary teeth); ectopic Wise reduces Wnt signaling and tooth number; Fgf and Shh pathways are major downstream targets; Shh acts as a negative-feedback regulator of Wnt signaling to determine vestigial bud fate.","method":"Knockout and genetic dosage reduction (Lrp5/Lrp6 hypomorphs), gain-of-function Wise overexpression, epistasis analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic epistasis (KO rescue by Lrp5/6 dosage reduction), gain-of-function confirmation, multiple downstream pathway readouts; rigorous multi-method study","pmids":["20724449"],"is_preprint":false},{"year":2010,"finding":"Loss of USAG-1/SOSTDC1 in Col4a3-/- (Alport syndrome) mice substantially attenuates disease progression and normalizes glomerular basement membrane ultrastructure; USAG-1 and BMP-7 colocalize in the macula densa of distal tubules; in cultured mesangial cells, BMP-7 attenuates and USAG-1 enhances MMP-12 expression, suggesting USAG-1 promotes GBM degradation via crosstalk between tubules and glomerulus.","method":"Double-knockout mouse model, immunohistochemistry colocalization, cultured mesangial cell assay for MMP-12 expression","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — double-KO with defined disease phenotype and mechanistic in vitro follow-up identifying MMP-12 as effector; multiple methods","pmids":["20197625"],"is_preprint":false},{"year":2010,"finding":"Recombinant SOSTDC1 selectively blocks BMP-7-induced Smad phosphorylation in breast cancer cells without diminishing BMP-2 or Wnt3a-induced signaling, demonstrating ligand-selective BMP antagonism.","method":"Recombinant protein treatment of breast cancer cells, Western blot for Smad phosphorylation","journal":"Breast cancer research and treatment","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct biochemical assay with recombinant protein and multiple ligand controls; single lab, single study","pmids":["21113658"],"is_preprint":false},{"year":2012,"finding":"Loss of Sostdc1 in mammary gland, hair follicle, and vibrissa development increases placode number and size; Sostdc1 is essential for suppression of hair follicle fate in nipple epidermis; functions attributed largely to its ability to attenuate Wnt/β-catenin signaling.","method":"Sostdc1-null mouse model, developmental morphological and molecular analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined skin appendage phenotypes across multiple tissue types; Wnt/β-catenin pathway implicated by target gene expression","pmids":["22509524"],"is_preprint":false},{"year":2012,"finding":"Inactivation of Sostdc1 in adult pancreatic islets enhances insulin secretion and improves glucose homeostasis under high-fat diet conditions; this is associated with altered expression of BMP-responsive genes but not Wnt target genes in islets, indicating that Sostdc1 primarily regulates the BMP pathway in the murine pancreas.","method":"Global Sostdc1-knockout mouse model, high-fat diet metabolic challenge, BMP and Wnt target gene expression analysis in isolated islets","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KO with functional metabolic phenotype and pathway-selective gene expression analysis; single lab","pmids":["22829579"],"is_preprint":false},{"year":2013,"finding":"Sost and Sostdc1 emerge through ancestral genome duplication with non-overlapping expression domains; in the limb, elevated Wnt signaling in Sost-/-; Sostdc1-/- double-null mice causes misregulation of SHH signaling, ectopic activation of Sox9 in the digit 1 field, and preaxial polydactyly in a Gli1- and Gli3-dependent manner, demonstrating genetic redundancy and epistasis between SOSTDC1, Wnt, SHH, and Gli3 pathways in digit patterning.","method":"Single and double knockout mouse models, gene expression analysis (Sox9, Gli1, Gli3), genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — double-KO epistasis revealing non-cell-autonomous Wnt-SHH-Gli3 interaction; multiple pathway readouts and genetic rescue","pmids":["23994639"],"is_preprint":false},{"year":2014,"finding":"USAG-1/SOSTDC1 suppresses development of rudimentary incisors by antagonizing BMP-7; supplementation of BMP-7 to E15 USAG-1 mutant maxillary incisor primordia in explant culture and subrenal capsule transplantation rescues and promotes supernumerary tooth development, confirming USAG-1 as a functional BMP-7 antagonist in tooth development.","method":"Explant culture with BMP-7 supplementation, subrenal capsule transplantation, Smad phosphorylation and Msx1/Dlx2 expression assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro and in vivo rescue experiment with defined ligand (BMP-7), multiple signaling readouts; extends prior KO findings","pmids":["24816837"],"is_preprint":false},{"year":2014,"finding":"E4BP4 transcriptional repressor binds SOSTDC1 promoter and represses its expression in breast cancer cells; SOSTDC1 promoter is epigenetically silenced by CpG hypermethylation; shRNA knockdown of E4BP4 combined with demethylation (5'-Aza-dC) upregulates SOSTDC1 and inhibits cancer cell proliferation.","method":"Luciferase promoter assay, methylation-specific PCR, bisulfite sequencing, shRNA knockdown, 5'-Aza-dC demethylation","journal":"Cellular oncology (Dordrecht, Netherlands)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter luciferase assay identifying E4BP4 binding sites, methylation analysis, and functional KD; multiple orthogonal methods in single lab","pmids":["25338303"],"is_preprint":false},{"year":2015,"finding":"Overexpression of SOSTDC1 in thyroid cancer cells inhibits proliferation and induces G1/S arrest by suppressing cyclin A2 and cyclin E2 expression.","method":"Ectopic overexpression in thyroid cancer cell lines, flow cytometry cell cycle analysis, Western blot for cyclin A2/E2, xenograft tumor growth assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — overexpression with defined cell-cycle phenotype and downstream molecular target identification; single lab, single study","pmids":["26378658"],"is_preprint":false},{"year":2016,"finding":"Sostdc1 marks periosteal mesenchymal stem cells (MSCs); Sostdc1-/- mice show >2-fold more MSCs in fracture callus at day 5 post-fracture, resulting in accelerated cartilage callus formation and faster bone remodeling, establishing Sostdc1 as a promoter of MSC quiescence in the periosteum.","method":"Sostdc1-/- mouse model, femoral fracture model, flow cytometry quantification of MSC populations, histology","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with quantitative MSC analysis and histological fracture healing readouts; single lab","pmids":["27102547"],"is_preprint":false},{"year":2016,"finding":"RUNX2 and USAG-1/SOSTDC1 act antagonistically during tooth development; double-null Usag-1-/-/Runx2-/- mice show reduced supernumerary teeth compared to Usag-1 null and further tooth development compared to Runx2 null; RUNX2 inhibits BMP and/or Wnt signaling regulated by USAG-1, while BMP signaling independently induces RUNX2 expression.","method":"Double-knockout mouse model, morphological phenotypic analysis, Sox2 immunostaining of odontogenic epithelial cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — double-KO genetic epistasis establishing antagonistic relationship; single lab","pmids":["27518316"],"is_preprint":false},{"year":2016,"finding":"SOSTDC1 overexpression in NSCLC cells increases p21Cip and p27Kip levels, decreases Rb phosphorylation, and reduces E2F transcription activity, inhibiting cancer cell proliferation.","method":"Ectopic overexpression in NSCLC cell lines, Western blot for p21/p27/Rb phosphorylation/E2F, in vitro proliferation and in vivo xenograft assays","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — overexpression with defined pathway readouts; single lab, single study","pmids":["27087917"],"is_preprint":false},{"year":2017,"finding":"SOSTDC1 overexpression in follicular thyroid cancer cells inhibits proliferation, migration, invasion, and EMT by inhibiting PI3K/Akt and MAPK/Erk signaling pathways.","method":"Ectopic overexpression in FTC cell lines, Western blot for PI3K/Akt and MAPK/Erk phosphorylation, in vitro invasion/migration assays, xenograft","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — overexpression with defined pathway readouts for two signaling axes; single lab","pmids":["28551845"],"is_preprint":false},{"year":2018,"finding":"Shh positively regulates Sostdc1 expression in tooth development; reduction of Shh activity in vivo significantly reduces Sostdc1 expression; Sostdc1 loss and Shh suppression produce similar supernumerary cusp patterns; genetic interaction between Sostdc1 and Lrp (Wnt co-receptor) confirms that Shh inhibits cusp patterning through Wnt signaling via positive regulation of Sostdc1.","method":"In vivo Shh activity suppression, Sostdc1-/- and compound Sostdc1/Lrp mutant mice, molar cusp phenotypic analysis, expression analysis","journal":"Journal of dental research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic approach with pathway epistasis linking Shh→Sostdc1→Wnt axis; single lab but multiple genetic contexts","pmids":["30325689"],"is_preprint":false},{"year":2019,"finding":"Sostdc1 regulates NK cell maturation in a cell-extrinsic manner from both non-hematopoietic and hematopoietic sources; Sostdc1-/- NK cells show higher Tcf7 and Lef1 levels (Wnt targets), decreased Id2 in immature and transitional NK cells, altered Ly49 receptor repertoire, and hyporesponsiveness against MHC class I-deficient targets; reciprocal bone marrow transplants demonstrate cell-extrinsic regulation.","method":"Sostdc1-/- mouse model, reciprocal bone marrow transplantation, flow cytometry, NK killing assays in vitro and in vivo, gene expression analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with functional NK killing phenotype and BM transplant epistasis; multiple readouts in single lab","pmids":["30814306"],"is_preprint":false},{"year":2019,"finding":"Sostdc1 expressed in testicular Sertoli cells is a negative regulator of spermatogenesis; persistent transgenic expression of Sostdc1 in mature Sertoli cells causes reduced sperm counts; Sostdc1 selectively activates BMP target genes via phospho-Smad1/5/8 signaling in germ cells, leading to their apoptosis.","method":"Transgenic rat overexpression model, sperm count, Smad1/5/8 phosphorylation, apoptosis assays in germ cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function with defined cellular phenotype (germ cell apoptosis via BMP-Smad) and quantitative spermatogenesis readout; single lab","pmids":["31391487"],"is_preprint":false},{"year":2019,"finding":"SOSTDC1 inhibits BMP4 to maintain cancer stem cell traits (SOX2, NANOG); SOSTDC1 associates with ALCAM/CD166 (confirmed by co-immunoprecipitation, mass spectrometry, confocal microscopy, and competition ELISA); interaction is mediated by the N-terminal region of SOSTDC1 containing a sequence similar to the ALCAM-binding motif of CD6; SOSTDC1-ALCAM interaction activates Src and PI3K/AKT signaling; ALCAM also interacts with α2β1 and α1β1 integrins, providing a link to Src activation.","method":"Co-immunoprecipitation, mass spectrometry, confocal microscopy, competition ELISA, domain-mapping with N-terminal SOSTDC1 region, siRNA knockdown, blocking antibodies, in vivo metastasis model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reciprocal Co-IP confirmed by MS and confocal, domain mapping, functional rescue with blocking antibodies and in vivo metastasis assay; multiple orthogonal methods in single study","pmids":["32801337"],"is_preprint":false},{"year":2019,"finding":"The BMP antagonist SOSTDC1 restrains gastric cancer progression via inactivation of c-Jun (non-canonical BMP signaling) rather than canonical SMAD-dependent BMP pathway; JNK blockade attenuates cell proliferative and migratory advantages conferred by SOSTDC1 knockdown.","method":"SOSTDC1 knockdown/overexpression in gastric cancer cells, Western blot for c-Jun activation, JNK inhibitor rescue, lung metastasis in vivo model","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — KD/OE with pharmacological rescue implicating c-Jun/JNK as effector; single lab, relatively limited mechanistic depth in abstract","pmids":["31815038"],"is_preprint":false},{"year":2019,"finding":"Sostdc1, secreted when myeloma cells contact osteoblast lineage cells, inhibits both BMP2- and BMP7-mediated signaling and Wnt signaling in primary osteoblasts, suppressing their differentiation; Sostdc1 expression is induced in both cell types only when in direct contact.","method":"Co-culture of myeloma and osteoblast lineage cells, recombinant Sostdc1 treatment of primary osteoblasts, BMP and Wnt signaling assays, immunohistochemistry of in vivo 5TGM1 model bones","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein functional assay in primary osteoblasts combined with in vivo localization; single lab","pmids":["30776499"],"is_preprint":false},{"year":2020,"finding":"SOSTDC1, secreted by a subset of follicular helper T (TFH) cells and T-B cell border fibroblastic reticular cells, blocks the WNT-β-catenin axis in follicular regulatory T (TFR) cells to facilitate their differentiation; Sostdc1 ablation in TFH cells substantially reduces TFR cell numbers and elevates germinal center responses.","method":"Reporter mice, fate tracking, transcriptome analysis, Sostdc1 conditional ablation in TFH cells, TFR cell quantification, WNT-β-catenin pathway analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — fate tracking, transcriptome, and conditional cell-type-specific KO with mechanistic WNT pathway link; high-profile journal with multiple orthogonal methods","pmids":["32820125"],"is_preprint":false},{"year":2020,"finding":"SOSTDC1 forms a highly stable non-covalent dimer (unlike monomeric SOST); this dimeric state correlates with potent inhibition of multiple BMP signaling growth factors including GDF5 in a cell-based assay, while monomeric SOST is a very poor BMP antagonist, demonstrating that dimerization is mechanistically linked to BMP antagonism potency within the DAN family.","method":"Biophysical (SEC-MALS, analytical ultracentrifugation), biochemical (non-denaturing PAGE), structural techniques, cell-based BMP inhibition assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple biophysical methods establishing oligomeric state combined with functional cell-based assay; rigorous biochemical characterization in single study","pmids":["32779697"],"is_preprint":false},{"year":2021,"finding":"Local application of Usag-1 siRNA loaded in cationized gelatin to mandibular tooth germs promotes tooth development in Runx2-knockout mice (which model congenital tooth agenesis); subrenal capsule transplantation experiments confirm that Usag-1 knockdown rescues arrested tooth formation caused by Runx2 deficiency.","method":"In vivo siRNA delivery with cationized gelatin, renal capsule transplantation, tooth morphology analysis in Runx2-KO mice","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue of KO phenotype by targeted siRNA silencing in vivo; extends prior double-KO epistasis with a therapeutic approach","pmids":["34211084"],"is_preprint":false},{"year":2024,"finding":"Following Olaparib treatment, SOSTDC1 translocates to the nucleus in an importin-α-dependent manner; nuclear SOSTDC1 interacts with the N-terminus of CHD1 (chromatin helicase DNA-binding factor) to promote homologous recombination (HR) repair and breast tumor-initiating cell (BTIC) maintenance; nuclear SOSTDC1 binds β-TrCP binding motifs on CHD1, blocking β-TrCP-mediated CHD1 ubiquitination and degradation.","method":"Nuclear fractionation, Co-immunoprecipitation (SOSTDC1-CHD1, SOSTDC1-β-TrCP), importin-α dependency assay, HR repair assays, BTIC functional assays, SOSTDC1 knockdown sensitization to Olaparib","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear translocation with mechanism (importin-α), Co-IP identifying CHD1 and β-TrCP interactions, functional HR assay; single lab but multiple orthogonal mechanistic methods","pmids":["38864559"],"is_preprint":false},{"year":2025,"finding":"SOSTDC1 secreted by CD4+ T cells disrupts adipocyte lipid balance by promoting lipogenesis and inhibiting lipolysis through the LRP5/6-β-catenin pathway; T cell receptor (TCR) signaling amplifies SOSTDC1 secretion in CD4+ T cells; T cell-specific Sostdc1-deficient mice are protected against obesity-induced insulin resistance.","method":"T cell-specific KO mouse model, obesity/insulin resistance challenge, LRP5/6-β-catenin pathway analysis in adipocytes, TCR stimulation assays for SOSTDC1 secretion","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with metabolic phenotype and defined LRP5/6-β-catenin mechanism in adipocytes; single lab","pmids":["40173040"],"is_preprint":false},{"year":2026,"finding":"USAG-1/SOSTDC1 promotes ferroptosis in renal ischemia-reperfusion injury by competitively binding HSPA5 (a molecular chaperone), thereby disrupting the HSPA5-GPX4 interaction and destabilizing GPX4; USAG-1 truncation mutants that fail to bind HSPA5 do not promote GPX4 degradation or ferroptosis, confirming the USAG-1/HSPA5/GPX4 axis as the mechanistic basis.","method":"USAG-1 KO mouse model, Co-immunoprecipitation (USAG-1-HSPA5, HSPA5-GPX4), truncation mutagenesis of USAG-1, ferroptosis assays, GPX4 stability assays, human transplant kidney biopsies","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — Co-IP identifying USAG-1-HSPA5 interaction, truncation mutagenesis validating the interaction domain, functional ferroptosis rescue in vivo and in vitro; multiple orthogonal methods in single rigorous study","pmids":["42177164"],"is_preprint":false},{"year":2026,"finding":"Rosuvastatin decreases USAG-1 expression by increasing HOXA13 expression (HOXA13 siRNA knockdown experiments implicate HOXA13 as the transcriptional regulator of USAG-1); decreased USAG-1 activates BMP-7-Smad1/5/9 signaling to attenuate renal tubulointerstitial fibrosis.","method":"In vivo UUO/ischemia-reperfusion model, HOXA13 siRNA knockdown in MDCK cells, Western blot for USAG-1/BMP-7/Smad1/5/9 phosphorylation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — siRNA epistasis identifying HOXA13 as upstream regulator of USAG-1, with downstream BMP-7 Smad signaling readout; single lab","pmids":["42009708"],"is_preprint":false}],"current_model":"SOSTDC1 (USAG-1/Wise/ectodin) is a secreted, dimeric DAN-family protein that functions as a dual antagonist of BMP signaling (by directly binding BMPs and blocking receptor activation, primarily through BMP-7) and Wnt signaling (by inhibiting LRP5/6-dependent β-catenin signaling); it controls tooth number, renal protection, skin appendage patterning, NK and T cell maturation, and bone homeostasis through these two pathways, and additionally can translocate to the nucleus to interact with CHD1 and promote DNA repair in cancer cells, and promotes ferroptosis in kidney injury by competitively disrupting the HSPA5-GPX4 chaperone axis."},"narrative":{"mechanistic_narrative":"SOSTDC1 (USAG-1/Wise/ectodin) is a secreted DAN-family protein that acts as a dual extracellular antagonist of BMP and Wnt signaling to pattern epithelial appendages and protect tissues [PMID:15020244, PMID:20724449]. It directly binds BMPs and blocks BMP-mediated receptor activation, exhibiting ligand selectivity for BMP-7 while sparing BMP-2 and Wnt3a [PMID:15020244, PMID:21113658], and it inhibits LRP5/6-dependent Wnt/β-catenin signaling, with reciprocal Lrp5/Lrp6 dosage reduction rescuing its loss-of-function phenotypes [PMID:20724449]. Potent BMP antagonism is mechanistically tied to its formation of a stable non-covalent dimer, distinguishing it from the weak monomeric antagonist SOST [PMID:32779697]. Through these two pathways SOSTDC1 limits tooth number by promoting apoptosis of odontogenic mesenchyme downstream of enhanced BMP and Wnt signaling [PMID:17555714, PMID:18329379, PMID:24816837], suppresses ectopic skin appendage and digit formation [PMID:22509524, PMID:23994639], and confers renoprotection by restraining BMP-7 signaling in distal tubules, such that its loss attenuates acute, chronic, and Alport-model kidney injury [PMID:16341262, PMID:20197625]. SOSTDC1 also regulates immune cell fate cell-extrinsically, controlling NK cell maturation and driving follicular regulatory T cell differentiation by blocking the WNT-β-catenin axis [PMID:30814306, PMID:32820125]. In cancer it generally restrains proliferation, acting through canonical and non-canonical (c-Jun/JNK) BMP outputs and an ALCAM/CD166-Src-PI3K/AKT interaction that maintains stem-cell traits [PMID:32801337, PMID:31815038], and it acquires distinct non-secreted roles: nuclear translocation to stabilize CHD1 and promote homologous-recombination repair [PMID:38864559], and promotion of ferroptosis by competitively disrupting the HSPA5-GPX4 chaperone axis [PMID:42177164].","teleology":[{"year":2004,"claim":"Established the founding biochemical identity of SOSTDC1 as a direct BMP-binding antagonist, defining the molecular basis for all later signaling work.","evidence":"Recombinant protein binding and alkaline phosphatase assays in C2C12 cells plus Xenopus mRNA injection","pmids":["15020244"],"confidence":"High","gaps":["Which specific BMP ligands are bound was not resolved","No structural basis for the binding interface"]},{"year":2005,"claim":"Placed SOSTDC1 genetically upstream of BMP-7 in vivo, showing it is the central BMP regulator conferring renoprotection.","evidence":"USAG-1-null mice with Smad phosphorylation readout and BMP-7 neutralizing antibody rescue in acute and chronic renal injury","pmids":["16341262"],"confidence":"High","gaps":["Cell-type origin of the protective effect not dissected","Downstream effectors of renoprotection not identified here"]},{"year":2007,"claim":"Linked SOSTDC1 expression topography to its functional partner BMP-7 in both kidney and tooth, supporting a localized antagonism model.","evidence":"Immunohistochemistry and in situ hybridization across kidney development/injury and incisor primordia with apoptosis assays","pmids":["17943079","17555714"],"confidence":"Medium","gaps":["Colocalization does not prove direct local antagonism","Apoptotic mechanism downstream of BMP not fully mapped"]},{"year":2010,"claim":"Resolved the dual-pathway logic by demonstrating SOSTDC1 inhibits LRP5/6-dependent Wnt signaling in tooth development, with reciprocal genetic epistasis.","evidence":"Wise-null mice rescued by Lrp5/Lrp6 dosage reduction, gain-of-function overexpression, and Fgf/Shh downstream readouts","pmids":["20724449"],"confidence":"High","gaps":["Direct biochemical SOSTDC1-LRP5/6 interaction not shown here","Quantitative balance between BMP and Wnt inhibition unclear"]},{"year":2010,"claim":"Demonstrated ligand-selective BMP-7 antagonism and an effector (MMP-12) connecting SOSTDC1 loss to disease attenuation in the kidney.","evidence":"Recombinant SOSTDC1 selectivity assays in breast cancer cells and Col4a3/USAG-1 double-knockout Alport mice with mesangial MMP-12 assays","pmids":["21113658","20197625"],"confidence":"High","gaps":["Structural determinant of BMP-7 selectivity not defined","Tubule-to-glomerulus crosstalk mechanism inferred"]},{"year":2014,"claim":"Confirmed BMP-7 as the functional ligand in tooth development through ligand-supplementation rescue.","evidence":"BMP-7 supplementation in USAG-1 mutant incisor explants and subrenal capsule transplants with Smad/Msx1/Dlx2 readouts","pmids":["24816837"],"confidence":"High","gaps":["Relative Wnt contribution in this context not quantified"]},{"year":2014,"claim":"Identified upstream transcriptional and epigenetic control of SOSTDC1, explaining its silencing in cancer.","evidence":"E4BP4 promoter luciferase, bisulfite sequencing, shRNA and 5'-Aza-dC in breast cancer cells","pmids":["25338303"],"confidence":"Medium","gaps":["Generality of E4BP4 regulation across tissues unknown","Whether methylation alone or with E4BP4 dominates silencing unclear"]},{"year":2012,"claim":"Extended SOSTDC1 function to skin appendage and metabolic patterning, showing tissue-specific dominance of Wnt versus BMP outputs.","evidence":"Sostdc1-null mice analyzed for hair follicle/mammary placodes (Wnt) and pancreatic islet insulin secretion (BMP target genes)","pmids":["22509524","22829579"],"confidence":"Medium","gaps":["Mechanism of pathway choice per tissue not defined","Direct receptor interactions not tested"]},{"year":2013,"claim":"Revealed redundancy with Sost and a Wnt-SHH-Gli3 epistatic network governing digit patterning.","evidence":"Sost/Sostdc1 single and double knockouts with Sox9, Gli1, Gli3 expression analysis","pmids":["23994639"],"confidence":"High","gaps":["Direct molecular link between SOSTDC1 and SHH/Gli not established","Non-cell-autonomous signal mediator unidentified"]},{"year":2016,"claim":"Established SOSTDC1 roles in bone via MSC quiescence and antagonistic interplay with RUNX2 in tooth, broadening the regulatory network.","evidence":"Sostdc1-/- fracture callus MSC quantification and Usag-1/Runx2 double-knockout tooth phenotyping","pmids":["27102547","27518316"],"confidence":"Medium","gaps":["Direct RUNX2-SOSTDC1 regulatory mechanism not biochemically mapped","MSC-intrinsic versus niche effects not separated"]},{"year":2017,"claim":"Characterized SOSTDC1 tumor-suppressive outputs through cell-cycle and kinase-pathway control across multiple cancers.","evidence":"Overexpression in thyroid and NSCLC cells with cyclin/p21/p27/Rb/E2F and PI3K/Akt, MAPK/Erk readouts","pmids":["26378658","27087917","28551845"],"confidence":"Medium","gaps":["Whether effects are secreted-antagonist or intracellular not resolved","Direct upstream receptor for these signals not identified"]},{"year":2019,"claim":"Uncovered cell-extrinsic immune regulation by SOSTDC1, controlling NK maturation and TFR differentiation via Wnt-β-catenin.","evidence":"Sostdc1-/- and conditional KO mice, reciprocal bone marrow transplants, fate tracking, and WNT pathway analysis","pmids":["30814306","32820125"],"confidence":"High","gaps":["Receptor mediating immune-cell effects not defined","Whether BMP also contributes in immune contexts unclear"]},{"year":2019,"claim":"Expanded the mechanistic repertoire to non-canonical and receptor-coupled signaling, including a direct ALCAM/CD166 interaction driving stem-cell traits.","evidence":"Co-IP/MS/confocal/competition ELISA mapping SOSTDC1-ALCAM, domain mapping, and c-Jun/JNK rescue in gastric cancer; transgenic Sertoli BMP-Smad apoptosis; myeloma-osteoblast contact-dependent co-culture","pmids":["32801337","31815038","31391487","30776499"],"confidence":"High","gaps":["How secreted-antagonist and ALCAM-receptor roles are integrated unknown","Structural basis of ALCAM binding not solved"]},{"year":2020,"claim":"Provided the biophysical basis for antagonist potency by showing SOSTDC1 functions as a stable dimer within the DAN family.","evidence":"SEC-MALS, analytical ultracentrifugation, non-denaturing PAGE, and cell-based BMP/GDF5 inhibition assays comparing dimeric SOSTDC1 to monomeric SOST","pmids":["32779697"],"confidence":"High","gaps":["High-resolution structure of the SOSTDC1-BMP complex absent","Dimer interface residues not defined"]},{"year":2021,"claim":"Demonstrated therapeutic feasibility of SOSTDC1 silencing to rescue congenital tooth agenesis.","evidence":"In vivo Usag-1 siRNA delivery via cationized gelatin and renal capsule transplantation in Runx2-KO mice","pmids":["34211084"],"confidence":"Medium","gaps":["Durability and off-target effects of silencing not assessed","Translation to human odontogenesis untested"]},{"year":2024,"claim":"Revealed an unexpected intracellular, nuclear function whereby SOSTDC1 stabilizes CHD1 to promote DNA repair and chemoresistance.","evidence":"Nuclear fractionation, importin-α-dependent translocation, SOSTDC1-CHD1 and SOSTDC1-β-TrCP Co-IP, and HR repair/BTIC assays after Olaparib","pmids":["38864559"],"confidence":"Medium","gaps":["How a secreted protein accesses the nucleus mechanistically unclear","Single lab; reciprocal validation of CHD1 stabilization limited"]},{"year":2025,"claim":"Connected T-cell-derived SOSTDC1 to systemic metabolism through adipocyte LRP5/6-β-catenin signaling.","evidence":"T cell-specific Sostdc1 KO mice under obesity challenge with adipocyte Wnt pathway and TCR-stimulation secretion assays","pmids":["40173040"],"confidence":"Medium","gaps":["Direct SOSTDC1-LRP5/6 binding in adipocytes not shown","Relative role versus BMP in adipose unclear"]},{"year":2026,"claim":"Identified a chaperone-disrupting, pro-ferroptotic activity, showing SOSTDC1 competitively binds HSPA5 to destabilize GPX4 in kidney injury.","evidence":"USAG-1 KO mice, USAG-1-HSPA5 and HSPA5-GPX4 Co-IP, truncation mutagenesis, ferroptosis/GPX4 stability assays, and human transplant biopsies","pmids":["42177164"],"confidence":"High","gaps":["How extracellular antagonist activity relates to this intracellular axis unresolved","Structural HSPA5-binding determinant only mapped by truncation"]},{"year":null,"claim":"It remains unknown how SOSTDC1's distinct secreted-antagonist, receptor-coupled (ALCAM), nuclear (CHD1), and chaperone-disrupting (HSPA5) activities are spatially and functionally coordinated within a single cell.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model integrating extracellular and intracellular roles","No high-resolution structure of SOSTDC1 with any partner","Mechanism switching between secretion and nuclear translocation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,6,8,26]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,8,30]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,24,25]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,6,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,6,9,11]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[20,25]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[30]}],"complexes":[],"partners":["BMP7","LRP5","LRP6","ALCAM","CHD1","HSPA5","GPX4","BTRC"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6X4U4","full_name":"Sclerostin domain-containing protein 1","aliases":["Ectodermal BMP inhibitor","Ectodin","Uterine sensitization-associated gene 1 protein","USAG-1"],"length_aa":206,"mass_kda":23.3,"function":"May be involved in the onset of endometrial receptivity for implantation/sensitization for the decidual cell reaction Enhances Wnt signaling and inhibits TGF-beta signaling (By similarity). Directly antagonizes activity of BMP2, BMP4, BMP6 and BMP7 in a dose-dependent manner","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q6X4U4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SOSTDC1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SOSTDC1","total_profiled":1310},"omim":[{"mim_id":"609675","title":"SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1","url":"https://www.omim.org/entry/609675"},{"mim_id":"604270","title":"LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4","url":"https://www.omim.org/entry/604270"},{"mim_id":"300451","title":"ECTODYSPLASIN A; EDA","url":"https://www.omim.org/entry/300451"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Golgi apparatus","reliability":"Uncertain"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Nucleoli rim","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"choroid plexus","ntpm":233.3}],"url":"https://www.proteinatlas.org/search/SOSTDC1"},"hgnc":{"alias_symbol":["DKFZp564D206","USAG1","DAND7"],"prev_symbol":[]},"alphafold":{"accession":"Q6X4U4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6X4U4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6X4U4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6X4U4-F1-predicted_aligned_error_v6.png","plddt_mean":68.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SOSTDC1","jax_strain_url":"https://www.jax.org/strain/search?query=SOSTDC1"},"sequence":{"accession":"Q6X4U4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6X4U4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6X4U4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6X4U4"}},"corpus_meta":[{"pmid":"20724449","id":"PMC_20724449","title":"Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20724449","citation_count":173,"is_preprint":false},{"pmid":"16341262","id":"PMC_16341262","title":"Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16341262","citation_count":122,"is_preprint":false},{"pmid":"15020244","id":"PMC_15020244","title":"USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15020244","citation_count":120,"is_preprint":false},{"pmid":"19141669","id":"PMC_19141669","title":"Tinkering with the inductive mesenchyme: Sostdc1 uncovers the role of dental mesenchyme in limiting tooth induction.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19141669","citation_count":83,"is_preprint":false},{"pmid":"20197625","id":"PMC_20197625","title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20197625","citation_count":68,"is_preprint":false},{"pmid":"17943079","id":"PMC_17943079","title":"Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury.","date":"2007","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/17943079","citation_count":66,"is_preprint":false},{"pmid":"18329379","id":"PMC_18329379","title":"Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18329379","citation_count":57,"is_preprint":false},{"pmid":"17555714","id":"PMC_17555714","title":"Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17555714","citation_count":54,"is_preprint":false},{"pmid":"22509524","id":"PMC_22509524","title":"Sostdc1 defines the size and number of skin appendage placodes.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22509524","citation_count":50,"is_preprint":false},{"pmid":"23994639","id":"PMC_23994639","title":"Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23994639","citation_count":47,"is_preprint":false},{"pmid":"26378658","id":"PMC_26378658","title":"Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26378658","citation_count":40,"is_preprint":false},{"pmid":"28551845","id":"PMC_28551845","title":"SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.","date":"2017","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28551845","citation_count":39,"is_preprint":false},{"pmid":"21113658","id":"PMC_21113658","title":"SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.","date":"2010","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/21113658","citation_count":37,"is_preprint":false},{"pmid":"22829579","id":"PMC_22829579","title":"Inactivation of the dual Bmp/Wnt inhibitor Sostdc1 enhances pancreatic islet function.","date":"2012","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22829579","citation_count":35,"is_preprint":false},{"pmid":"32820125","id":"PMC_32820125","title":"SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32820125","citation_count":33,"is_preprint":false},{"pmid":"27102547","id":"PMC_27102547","title":"Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.","date":"2016","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/27102547","citation_count":33,"is_preprint":false},{"pmid":"24816837","id":"PMC_24816837","title":"Interactions between BMP-7 and USAG-1 (uterine sensitization-associated gene-1) regulate supernumerary organ formations.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24816837","citation_count":33,"is_preprint":false},{"pmid":"19760604","id":"PMC_19760604","title":"Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.","date":"2009","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19760604","citation_count":30,"is_preprint":false},{"pmid":"25338303","id":"PMC_25338303","title":"E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.","date":"2014","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/25338303","citation_count":25,"is_preprint":false},{"pmid":"32801337","id":"PMC_32801337","title":"SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32801337","citation_count":24,"is_preprint":false},{"pmid":"27087917","id":"PMC_27087917","title":"SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.","date":"2016","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/27087917","citation_count":24,"is_preprint":false},{"pmid":"31313025","id":"PMC_31313025","title":"MiR-26a promotes fracture healing of nonunion rats possibly by targeting SOSTDC1 and further activating Wnt/β-catenin signaling pathway.","date":"2019","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31313025","citation_count":20,"is_preprint":false},{"pmid":"30320379","id":"PMC_30320379","title":"SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30320379","citation_count":19,"is_preprint":false},{"pmid":"27518316","id":"PMC_27518316","title":"Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27518316","citation_count":19,"is_preprint":false},{"pmid":"21221677","id":"PMC_21221677","title":"Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men.","date":"2011","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21221677","citation_count":18,"is_preprint":false},{"pmid":"30325689","id":"PMC_30325689","title":"Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/30325689","citation_count":18,"is_preprint":false},{"pmid":"21080955","id":"PMC_21080955","title":"Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.","date":"2010","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/21080955","citation_count":17,"is_preprint":false},{"pmid":"34211084","id":"PMC_34211084","title":"Local application of Usag-1 siRNA can promote tooth regeneration in Runx2-deficient mice.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34211084","citation_count":17,"is_preprint":false},{"pmid":"30814306","id":"PMC_30814306","title":"Sostdc1 Regulates NK Cell Maturation and Cytotoxicity.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30814306","citation_count":14,"is_preprint":false},{"pmid":"30628645","id":"PMC_30628645","title":"Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30628645","citation_count":14,"is_preprint":false},{"pmid":"30367460","id":"PMC_30367460","title":"Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause profibrotic changes in linear morphoea fibroblasts.","date":"2019","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30367460","citation_count":13,"is_preprint":false},{"pmid":"30776499","id":"PMC_30776499","title":"Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells.","date":"2019","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/30776499","citation_count":13,"is_preprint":false},{"pmid":"31815038","id":"PMC_31815038","title":"The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31815038","citation_count":13,"is_preprint":false},{"pmid":"26680283","id":"PMC_26680283","title":"Febuxostat Prevents Renal Interstitial Fibrosis by the Activation of BMP-7 Signaling and Inhibition of USAG-1 Expression in Rats.","date":"2015","source":"American journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/26680283","citation_count":13,"is_preprint":false},{"pmid":"36338475","id":"PMC_36338475","title":"Role of Sostdc1 in skeletal biology and cancer.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36338475","citation_count":12,"is_preprint":false},{"pmid":"35138469","id":"PMC_35138469","title":"Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis.","date":"2022","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35138469","citation_count":10,"is_preprint":false},{"pmid":"35678675","id":"PMC_35678675","title":"Sostdc1 Secreted from Cutaneous Lymphatic Vessels Acts as a Paracrine Factor for Hair Follicle Growth.","date":"2022","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35678675","citation_count":10,"is_preprint":false},{"pmid":"34110955","id":"PMC_34110955","title":"lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.","date":"2021","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/34110955","citation_count":9,"is_preprint":false},{"pmid":"32779697","id":"PMC_32779697","title":"Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST.","date":"2020","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32779697","citation_count":9,"is_preprint":false},{"pmid":"31391487","id":"PMC_31391487","title":"Downregulation of Sostdc1 in Testicular Sertoli Cells is Prerequisite for Onset of Robust Spermatogenesis at Puberty.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31391487","citation_count":9,"is_preprint":false},{"pmid":"40173040","id":"PMC_40173040","title":"SOSTDC1 downregulation in CD4+ T cells confers protection against obesity-induced insulin resistance.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/40173040","citation_count":8,"is_preprint":false},{"pmid":"38152045","id":"PMC_38152045","title":"MiR-22-3p facilitates bone marrow mesenchymal stem cell osteogenesis and fracture healing through the SOSTDC1-PI3K/AKT pathway.","date":"2023","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/38152045","citation_count":8,"is_preprint":false},{"pmid":"27178071","id":"PMC_27178071","title":"Effects of Usag-1 and Bmp7 deficiencies on murine tooth morphogenesis.","date":"2016","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27178071","citation_count":8,"is_preprint":false},{"pmid":"39956898","id":"PMC_39956898","title":"MicroRNA-27a transfected dental pulp stem cells undergo odonto/osteogenic differentiation via targeting DKK3 and SOSTDC1 in Wnt/BMP signaling in vitro and enhance bone formation in vivo.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39956898","citation_count":6,"is_preprint":false},{"pmid":"35442555","id":"PMC_35442555","title":"SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway.","date":"2022","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35442555","citation_count":6,"is_preprint":false},{"pmid":"38864559","id":"PMC_38864559","title":"SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38864559","citation_count":5,"is_preprint":false},{"pmid":"30148467","id":"PMC_30148467","title":"Investigation of SOSTDC1 gene in non-syndromic patients with supernumerary teeth.","date":"2018","source":"Medicina oral, patologia oral y cirugia bucal","url":"https://pubmed.ncbi.nlm.nih.gov/30148467","citation_count":4,"is_preprint":false},{"pmid":"17389776","id":"PMC_17389776","title":"Expression of uterine sensitization-associated gene-1 (USAG-1) in the mouse uterus during the peri-implantation period.","date":"2007","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/17389776","citation_count":4,"is_preprint":false},{"pmid":"31133012","id":"PMC_31133012","title":"Lack of association between PAX6/SOSTDC1/FAM20B gene polymorphisms and mesiodens.","date":"2019","source":"BMC oral health","url":"https://pubmed.ncbi.nlm.nih.gov/31133012","citation_count":3,"is_preprint":false},{"pmid":"39326466","id":"PMC_39326466","title":"miR4352b a cross-species modulator of SOSTDC1, targets dual pathway to regulate bone health and fracture healing.","date":"2024","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/39326466","citation_count":3,"is_preprint":false},{"pmid":"31529323","id":"PMC_31529323","title":"Sostdc1 is expressed in all major compartments of developing and adult mammalian eyes.","date":"2019","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/31529323","citation_count":2,"is_preprint":false},{"pmid":"41632902","id":"PMC_41632902","title":"USAG-1 and Regenerative Dentistry, Therapeutic Implications and Future Directions: Review of the Literature.","date":"2026","source":"Clinical and experimental dental research","url":"https://pubmed.ncbi.nlm.nih.gov/41632902","citation_count":1,"is_preprint":false},{"pmid":"42009708","id":"PMC_42009708","title":"Rosuvastatin attenuates tubulointerstitial fibrosis by targeting the HOXA13 USAG1 BMP7 pathway.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/42009708","citation_count":0,"is_preprint":false},{"pmid":"41520687","id":"PMC_41520687","title":"Inhibition of USAG-1 improved delayed graft function in renal transplantation.","date":"2026","source":"Transplant immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41520687","citation_count":0,"is_preprint":false},{"pmid":"42177164","id":"PMC_42177164","title":"USAG-1 aggravates renal ischemia‒reperfusion injury via promoting GPX4 degradation-induced ferroptosis.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/42177164","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":30654,"output_tokens":8223,"usd":0.107653,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18043,"output_tokens":5358,"usd":0.112083,"stage2_stop_reason":"end_turn"},"total_usd":0.219736,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"USAG-1/SOSTDC1 recombinant protein directly binds BMPs and antagonizes BMP-mediated induction of alkaline phosphatase in C2C12 cells; injection of USAG-1 mRNA into Xenopus embryos induces secondary axis formation and hyperdorsalization, establishing it as a BMP antagonist.\",\n      \"method\": \"Recombinant protein binding assay, alkaline phosphatase in vitro cell assay, Xenopus mRNA injection\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biochemical binding assay and functional cell-based assay plus in vivo Xenopus validation in a single study, multiple orthogonal methods\",\n      \"pmids\": [\"15020244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"USAG-1/SOSTDC1 is the central negative regulator of BMP function in the kidney; USAG-1-null mice show enhanced phosphorylation of Smad proteins (BMP signaling) and are resistant to acute and chronic renal injury; neutralizing antibody against BMP-7 abolishes renoprotection in USAG-1-null mice, placing USAG-1 upstream of BMP-7 in renal injury signaling.\",\n      \"method\": \"Knockout mouse model, Smad phosphorylation assay, neutralizing antibody treatment in vivo\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined renal phenotype, Smad phosphorylation readout, antibody rescue experiment confirming BMP-7 dependence; replicated across acute and chronic models\",\n      \"pmids\": [\"16341262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"USAG-1/SOSTDC1 is localized in distal renal tubules overlapping with BMP-7 expression; its expression ratio to BMP-7 increases dramatically during later kidney development and after renal regeneration, consistent with its role as the BMP-7 regulatory counterpart in kidney.\",\n      \"method\": \"Immunohistochemistry, in situ hybridization, expression analysis during kidney development and injury models\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization by immunohistochemistry replicated across developmental and injury contexts, functional link inferred from prior KO studies\",\n      \"pmids\": [\"17943079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"USAG-1/SOSTDC1 is expressed in the epithelium and mesenchyme of the rudimentary maxillary incisor and its abrogation rescues apoptotic elimination of odontogenic mesenchymal cells, leading to supernumerary tooth formation; USAG-1 controls tooth number by regulating apoptosis in this region.\",\n      \"method\": \"Knockout mouse model, localization by in situ hybridization/immunohistochemistry, apoptosis assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined cellular phenotype (apoptosis rescue, supernumerary teeth), localization confirmed; single lab\",\n      \"pmids\": [\"17555714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In USAG-1/SOSTDC1-null mice, BMP signaling (assessed by Msx1, Dlx2 expression and Smad phosphorylation) is significantly enhanced in the rudimentary maxillary incisor; Wnt signaling (nuclear β-catenin) is also upregulated; inhibition of BMP signaling in explant culture rescues supernumerary tooth formation, demonstrating that enhanced BMP signaling drives the supernumerary tooth phenotype downstream of USAG-1 loss.\",\n      \"method\": \"Knockout mouse model, Smad phosphorylation assay, β-catenin nuclear localization, BMP inhibitor rescue in explant culture\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple signaling readouts plus pharmacological rescue experiment in organ culture; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"18329379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SOSTDC1 expressed in dental mesenchyme limits supernumerary incisor induction; reducing mesenchymal tissue around tooth germs in vitro phenocopies the Sostdc1-null extra incisor; both Noggin and Dkk1 individually prevent extra incisor formation, demonstrating that inhibition of both BMP and Wnt signaling contribute to the inhibitory role of dental mesenchyme.\",\n      \"method\": \"Sostdc1-null mouse model, in vitro organ culture with tissue reduction, Noggin and Dkk1 treatment rescue experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genetic KO combined with in vitro rescue with pathway-specific inhibitors; multiple orthogonal approaches in single study\",\n      \"pmids\": [\"19141669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SOSTDC1/Wise inhibits Lrp5- and Lrp6-dependent Wnt signaling in tooth development; genetic reduction of Lrp5 and Lrp6 dosage rescues the Wise-null tooth phenotypes (supernumerary teeth); ectopic Wise reduces Wnt signaling and tooth number; Fgf and Shh pathways are major downstream targets; Shh acts as a negative-feedback regulator of Wnt signaling to determine vestigial bud fate.\",\n      \"method\": \"Knockout and genetic dosage reduction (Lrp5/Lrp6 hypomorphs), gain-of-function Wise overexpression, epistasis analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic epistasis (KO rescue by Lrp5/6 dosage reduction), gain-of-function confirmation, multiple downstream pathway readouts; rigorous multi-method study\",\n      \"pmids\": [\"20724449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss of USAG-1/SOSTDC1 in Col4a3-/- (Alport syndrome) mice substantially attenuates disease progression and normalizes glomerular basement membrane ultrastructure; USAG-1 and BMP-7 colocalize in the macula densa of distal tubules; in cultured mesangial cells, BMP-7 attenuates and USAG-1 enhances MMP-12 expression, suggesting USAG-1 promotes GBM degradation via crosstalk between tubules and glomerulus.\",\n      \"method\": \"Double-knockout mouse model, immunohistochemistry colocalization, cultured mesangial cell assay for MMP-12 expression\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double-KO with defined disease phenotype and mechanistic in vitro follow-up identifying MMP-12 as effector; multiple methods\",\n      \"pmids\": [\"20197625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Recombinant SOSTDC1 selectively blocks BMP-7-induced Smad phosphorylation in breast cancer cells without diminishing BMP-2 or Wnt3a-induced signaling, demonstrating ligand-selective BMP antagonism.\",\n      \"method\": \"Recombinant protein treatment of breast cancer cells, Western blot for Smad phosphorylation\",\n      \"journal\": \"Breast cancer research and treatment\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct biochemical assay with recombinant protein and multiple ligand controls; single lab, single study\",\n      \"pmids\": [\"21113658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss of Sostdc1 in mammary gland, hair follicle, and vibrissa development increases placode number and size; Sostdc1 is essential for suppression of hair follicle fate in nipple epidermis; functions attributed largely to its ability to attenuate Wnt/β-catenin signaling.\",\n      \"method\": \"Sostdc1-null mouse model, developmental morphological and molecular analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined skin appendage phenotypes across multiple tissue types; Wnt/β-catenin pathway implicated by target gene expression\",\n      \"pmids\": [\"22509524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Inactivation of Sostdc1 in adult pancreatic islets enhances insulin secretion and improves glucose homeostasis under high-fat diet conditions; this is associated with altered expression of BMP-responsive genes but not Wnt target genes in islets, indicating that Sostdc1 primarily regulates the BMP pathway in the murine pancreas.\",\n      \"method\": \"Global Sostdc1-knockout mouse model, high-fat diet metabolic challenge, BMP and Wnt target gene expression analysis in isolated islets\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KO with functional metabolic phenotype and pathway-selective gene expression analysis; single lab\",\n      \"pmids\": [\"22829579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Sost and Sostdc1 emerge through ancestral genome duplication with non-overlapping expression domains; in the limb, elevated Wnt signaling in Sost-/-; Sostdc1-/- double-null mice causes misregulation of SHH signaling, ectopic activation of Sox9 in the digit 1 field, and preaxial polydactyly in a Gli1- and Gli3-dependent manner, demonstrating genetic redundancy and epistasis between SOSTDC1, Wnt, SHH, and Gli3 pathways in digit patterning.\",\n      \"method\": \"Single and double knockout mouse models, gene expression analysis (Sox9, Gli1, Gli3), genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double-KO epistasis revealing non-cell-autonomous Wnt-SHH-Gli3 interaction; multiple pathway readouts and genetic rescue\",\n      \"pmids\": [\"23994639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USAG-1/SOSTDC1 suppresses development of rudimentary incisors by antagonizing BMP-7; supplementation of BMP-7 to E15 USAG-1 mutant maxillary incisor primordia in explant culture and subrenal capsule transplantation rescues and promotes supernumerary tooth development, confirming USAG-1 as a functional BMP-7 antagonist in tooth development.\",\n      \"method\": \"Explant culture with BMP-7 supplementation, subrenal capsule transplantation, Smad phosphorylation and Msx1/Dlx2 expression assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro and in vivo rescue experiment with defined ligand (BMP-7), multiple signaling readouts; extends prior KO findings\",\n      \"pmids\": [\"24816837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"E4BP4 transcriptional repressor binds SOSTDC1 promoter and represses its expression in breast cancer cells; SOSTDC1 promoter is epigenetically silenced by CpG hypermethylation; shRNA knockdown of E4BP4 combined with demethylation (5'-Aza-dC) upregulates SOSTDC1 and inhibits cancer cell proliferation.\",\n      \"method\": \"Luciferase promoter assay, methylation-specific PCR, bisulfite sequencing, shRNA knockdown, 5'-Aza-dC demethylation\",\n      \"journal\": \"Cellular oncology (Dordrecht, Netherlands)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter luciferase assay identifying E4BP4 binding sites, methylation analysis, and functional KD; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"25338303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Overexpression of SOSTDC1 in thyroid cancer cells inhibits proliferation and induces G1/S arrest by suppressing cyclin A2 and cyclin E2 expression.\",\n      \"method\": \"Ectopic overexpression in thyroid cancer cell lines, flow cytometry cell cycle analysis, Western blot for cyclin A2/E2, xenograft tumor growth assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — overexpression with defined cell-cycle phenotype and downstream molecular target identification; single lab, single study\",\n      \"pmids\": [\"26378658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sostdc1 marks periosteal mesenchymal stem cells (MSCs); Sostdc1-/- mice show >2-fold more MSCs in fracture callus at day 5 post-fracture, resulting in accelerated cartilage callus formation and faster bone remodeling, establishing Sostdc1 as a promoter of MSC quiescence in the periosteum.\",\n      \"method\": \"Sostdc1-/- mouse model, femoral fracture model, flow cytometry quantification of MSC populations, histology\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with quantitative MSC analysis and histological fracture healing readouts; single lab\",\n      \"pmids\": [\"27102547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RUNX2 and USAG-1/SOSTDC1 act antagonistically during tooth development; double-null Usag-1-/-/Runx2-/- mice show reduced supernumerary teeth compared to Usag-1 null and further tooth development compared to Runx2 null; RUNX2 inhibits BMP and/or Wnt signaling regulated by USAG-1, while BMP signaling independently induces RUNX2 expression.\",\n      \"method\": \"Double-knockout mouse model, morphological phenotypic analysis, Sox2 immunostaining of odontogenic epithelial cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double-KO genetic epistasis establishing antagonistic relationship; single lab\",\n      \"pmids\": [\"27518316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SOSTDC1 overexpression in NSCLC cells increases p21Cip and p27Kip levels, decreases Rb phosphorylation, and reduces E2F transcription activity, inhibiting cancer cell proliferation.\",\n      \"method\": \"Ectopic overexpression in NSCLC cell lines, Western blot for p21/p27/Rb phosphorylation/E2F, in vitro proliferation and in vivo xenograft assays\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — overexpression with defined pathway readouts; single lab, single study\",\n      \"pmids\": [\"27087917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SOSTDC1 overexpression in follicular thyroid cancer cells inhibits proliferation, migration, invasion, and EMT by inhibiting PI3K/Akt and MAPK/Erk signaling pathways.\",\n      \"method\": \"Ectopic overexpression in FTC cell lines, Western blot for PI3K/Akt and MAPK/Erk phosphorylation, in vitro invasion/migration assays, xenograft\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — overexpression with defined pathway readouts for two signaling axes; single lab\",\n      \"pmids\": [\"28551845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Shh positively regulates Sostdc1 expression in tooth development; reduction of Shh activity in vivo significantly reduces Sostdc1 expression; Sostdc1 loss and Shh suppression produce similar supernumerary cusp patterns; genetic interaction between Sostdc1 and Lrp (Wnt co-receptor) confirms that Shh inhibits cusp patterning through Wnt signaling via positive regulation of Sostdc1.\",\n      \"method\": \"In vivo Shh activity suppression, Sostdc1-/- and compound Sostdc1/Lrp mutant mice, molar cusp phenotypic analysis, expression analysis\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic approach with pathway epistasis linking Shh→Sostdc1→Wnt axis; single lab but multiple genetic contexts\",\n      \"pmids\": [\"30325689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sostdc1 regulates NK cell maturation in a cell-extrinsic manner from both non-hematopoietic and hematopoietic sources; Sostdc1-/- NK cells show higher Tcf7 and Lef1 levels (Wnt targets), decreased Id2 in immature and transitional NK cells, altered Ly49 receptor repertoire, and hyporesponsiveness against MHC class I-deficient targets; reciprocal bone marrow transplants demonstrate cell-extrinsic regulation.\",\n      \"method\": \"Sostdc1-/- mouse model, reciprocal bone marrow transplantation, flow cytometry, NK killing assays in vitro and in vivo, gene expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with functional NK killing phenotype and BM transplant epistasis; multiple readouts in single lab\",\n      \"pmids\": [\"30814306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sostdc1 expressed in testicular Sertoli cells is a negative regulator of spermatogenesis; persistent transgenic expression of Sostdc1 in mature Sertoli cells causes reduced sperm counts; Sostdc1 selectively activates BMP target genes via phospho-Smad1/5/8 signaling in germ cells, leading to their apoptosis.\",\n      \"method\": \"Transgenic rat overexpression model, sperm count, Smad1/5/8 phosphorylation, apoptosis assays in germ cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function with defined cellular phenotype (germ cell apoptosis via BMP-Smad) and quantitative spermatogenesis readout; single lab\",\n      \"pmids\": [\"31391487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SOSTDC1 inhibits BMP4 to maintain cancer stem cell traits (SOX2, NANOG); SOSTDC1 associates with ALCAM/CD166 (confirmed by co-immunoprecipitation, mass spectrometry, confocal microscopy, and competition ELISA); interaction is mediated by the N-terminal region of SOSTDC1 containing a sequence similar to the ALCAM-binding motif of CD6; SOSTDC1-ALCAM interaction activates Src and PI3K/AKT signaling; ALCAM also interacts with α2β1 and α1β1 integrins, providing a link to Src activation.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, confocal microscopy, competition ELISA, domain-mapping with N-terminal SOSTDC1 region, siRNA knockdown, blocking antibodies, in vivo metastasis model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reciprocal Co-IP confirmed by MS and confocal, domain mapping, functional rescue with blocking antibodies and in vivo metastasis assay; multiple orthogonal methods in single study\",\n      \"pmids\": [\"32801337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The BMP antagonist SOSTDC1 restrains gastric cancer progression via inactivation of c-Jun (non-canonical BMP signaling) rather than canonical SMAD-dependent BMP pathway; JNK blockade attenuates cell proliferative and migratory advantages conferred by SOSTDC1 knockdown.\",\n      \"method\": \"SOSTDC1 knockdown/overexpression in gastric cancer cells, Western blot for c-Jun activation, JNK inhibitor rescue, lung metastasis in vivo model\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — KD/OE with pharmacological rescue implicating c-Jun/JNK as effector; single lab, relatively limited mechanistic depth in abstract\",\n      \"pmids\": [\"31815038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sostdc1, secreted when myeloma cells contact osteoblast lineage cells, inhibits both BMP2- and BMP7-mediated signaling and Wnt signaling in primary osteoblasts, suppressing their differentiation; Sostdc1 expression is induced in both cell types only when in direct contact.\",\n      \"method\": \"Co-culture of myeloma and osteoblast lineage cells, recombinant Sostdc1 treatment of primary osteoblasts, BMP and Wnt signaling assays, immunohistochemistry of in vivo 5TGM1 model bones\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein functional assay in primary osteoblasts combined with in vivo localization; single lab\",\n      \"pmids\": [\"30776499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOSTDC1, secreted by a subset of follicular helper T (TFH) cells and T-B cell border fibroblastic reticular cells, blocks the WNT-β-catenin axis in follicular regulatory T (TFR) cells to facilitate their differentiation; Sostdc1 ablation in TFH cells substantially reduces TFR cell numbers and elevates germinal center responses.\",\n      \"method\": \"Reporter mice, fate tracking, transcriptome analysis, Sostdc1 conditional ablation in TFH cells, TFR cell quantification, WNT-β-catenin pathway analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — fate tracking, transcriptome, and conditional cell-type-specific KO with mechanistic WNT pathway link; high-profile journal with multiple orthogonal methods\",\n      \"pmids\": [\"32820125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOSTDC1 forms a highly stable non-covalent dimer (unlike monomeric SOST); this dimeric state correlates with potent inhibition of multiple BMP signaling growth factors including GDF5 in a cell-based assay, while monomeric SOST is a very poor BMP antagonist, demonstrating that dimerization is mechanistically linked to BMP antagonism potency within the DAN family.\",\n      \"method\": \"Biophysical (SEC-MALS, analytical ultracentrifugation), biochemical (non-denaturing PAGE), structural techniques, cell-based BMP inhibition assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple biophysical methods establishing oligomeric state combined with functional cell-based assay; rigorous biochemical characterization in single study\",\n      \"pmids\": [\"32779697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Local application of Usag-1 siRNA loaded in cationized gelatin to mandibular tooth germs promotes tooth development in Runx2-knockout mice (which model congenital tooth agenesis); subrenal capsule transplantation experiments confirm that Usag-1 knockdown rescues arrested tooth formation caused by Runx2 deficiency.\",\n      \"method\": \"In vivo siRNA delivery with cationized gelatin, renal capsule transplantation, tooth morphology analysis in Runx2-KO mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue of KO phenotype by targeted siRNA silencing in vivo; extends prior double-KO epistasis with a therapeutic approach\",\n      \"pmids\": [\"34211084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Following Olaparib treatment, SOSTDC1 translocates to the nucleus in an importin-α-dependent manner; nuclear SOSTDC1 interacts with the N-terminus of CHD1 (chromatin helicase DNA-binding factor) to promote homologous recombination (HR) repair and breast tumor-initiating cell (BTIC) maintenance; nuclear SOSTDC1 binds β-TrCP binding motifs on CHD1, blocking β-TrCP-mediated CHD1 ubiquitination and degradation.\",\n      \"method\": \"Nuclear fractionation, Co-immunoprecipitation (SOSTDC1-CHD1, SOSTDC1-β-TrCP), importin-α dependency assay, HR repair assays, BTIC functional assays, SOSTDC1 knockdown sensitization to Olaparib\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear translocation with mechanism (importin-α), Co-IP identifying CHD1 and β-TrCP interactions, functional HR assay; single lab but multiple orthogonal mechanistic methods\",\n      \"pmids\": [\"38864559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SOSTDC1 secreted by CD4+ T cells disrupts adipocyte lipid balance by promoting lipogenesis and inhibiting lipolysis through the LRP5/6-β-catenin pathway; T cell receptor (TCR) signaling amplifies SOSTDC1 secretion in CD4+ T cells; T cell-specific Sostdc1-deficient mice are protected against obesity-induced insulin resistance.\",\n      \"method\": \"T cell-specific KO mouse model, obesity/insulin resistance challenge, LRP5/6-β-catenin pathway analysis in adipocytes, TCR stimulation assays for SOSTDC1 secretion\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with metabolic phenotype and defined LRP5/6-β-catenin mechanism in adipocytes; single lab\",\n      \"pmids\": [\"40173040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USAG-1/SOSTDC1 promotes ferroptosis in renal ischemia-reperfusion injury by competitively binding HSPA5 (a molecular chaperone), thereby disrupting the HSPA5-GPX4 interaction and destabilizing GPX4; USAG-1 truncation mutants that fail to bind HSPA5 do not promote GPX4 degradation or ferroptosis, confirming the USAG-1/HSPA5/GPX4 axis as the mechanistic basis.\",\n      \"method\": \"USAG-1 KO mouse model, Co-immunoprecipitation (USAG-1-HSPA5, HSPA5-GPX4), truncation mutagenesis of USAG-1, ferroptosis assays, GPX4 stability assays, human transplant kidney biopsies\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — Co-IP identifying USAG-1-HSPA5 interaction, truncation mutagenesis validating the interaction domain, functional ferroptosis rescue in vivo and in vitro; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"42177164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Rosuvastatin decreases USAG-1 expression by increasing HOXA13 expression (HOXA13 siRNA knockdown experiments implicate HOXA13 as the transcriptional regulator of USAG-1); decreased USAG-1 activates BMP-7-Smad1/5/9 signaling to attenuate renal tubulointerstitial fibrosis.\",\n      \"method\": \"In vivo UUO/ischemia-reperfusion model, HOXA13 siRNA knockdown in MDCK cells, Western blot for USAG-1/BMP-7/Smad1/5/9 phosphorylation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — siRNA epistasis identifying HOXA13 as upstream regulator of USAG-1, with downstream BMP-7 Smad signaling readout; single lab\",\n      \"pmids\": [\"42009708\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SOSTDC1 (USAG-1/Wise/ectodin) is a secreted, dimeric DAN-family protein that functions as a dual antagonist of BMP signaling (by directly binding BMPs and blocking receptor activation, primarily through BMP-7) and Wnt signaling (by inhibiting LRP5/6-dependent β-catenin signaling); it controls tooth number, renal protection, skin appendage patterning, NK and T cell maturation, and bone homeostasis through these two pathways, and additionally can translocate to the nucleus to interact with CHD1 and promote DNA repair in cancer cells, and promotes ferroptosis in kidney injury by competitively disrupting the HSPA5-GPX4 chaperone axis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SOSTDC1 (USAG-1/Wise/ectodin) is a secreted DAN-family protein that acts as a dual extracellular antagonist of BMP and Wnt signaling to pattern epithelial appendages and protect tissues [#0, #6]. It directly binds BMPs and blocks BMP-mediated receptor activation, exhibiting ligand selectivity for BMP-7 while sparing BMP-2 and Wnt3a [#0, #8], and it inhibits LRP5/6-dependent Wnt/\\u03b2-catenin signaling, with reciprocal Lrp5/Lrp6 dosage reduction rescuing its loss-of-function phenotypes [#6]. Potent BMP antagonism is mechanistically tied to its formation of a stable non-covalent dimer, distinguishing it from the weak monomeric antagonist SOST [#26]. Through these two pathways SOSTDC1 limits tooth number by promoting apoptosis of odontogenic mesenchyme downstream of enhanced BMP and Wnt signaling [#3, #4, #12], suppresses ectopic skin appendage and digit formation [#9, #11], and confers renoprotection by restraining BMP-7 signaling in distal tubules, such that its loss attenuates acute, chronic, and Alport-model kidney injury [#1, #7]. SOSTDC1 also regulates immune cell fate cell-extrinsically, controlling NK cell maturation and driving follicular regulatory T cell differentiation by blocking the WNT-\\u03b2-catenin axis [#20, #25]. In cancer it generally restrains proliferation, acting through canonical and non-canonical (c-Jun/JNK) BMP outputs and an ALCAM/CD166-Src-PI3K/AKT interaction that maintains stem-cell traits [#22, #23], and it acquires distinct non-secreted roles: nuclear translocation to stabilize CHD1 and promote homologous-recombination repair [#28], and promotion of ferroptosis by competitively disrupting the HSPA5-GPX4 chaperone axis [#30].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the founding biochemical identity of SOSTDC1 as a direct BMP-binding antagonist, defining the molecular basis for all later signaling work.\",\n      \"evidence\": \"Recombinant protein binding and alkaline phosphatase assays in C2C12 cells plus Xenopus mRNA injection\",\n      \"pmids\": [\"15020244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific BMP ligands are bound was not resolved\", \"No structural basis for the binding interface\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placed SOSTDC1 genetically upstream of BMP-7 in vivo, showing it is the central BMP regulator conferring renoprotection.\",\n      \"evidence\": \"USAG-1-null mice with Smad phosphorylation readout and BMP-7 neutralizing antibody rescue in acute and chronic renal injury\",\n      \"pmids\": [\"16341262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type origin of the protective effect not dissected\", \"Downstream effectors of renoprotection not identified here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linked SOSTDC1 expression topography to its functional partner BMP-7 in both kidney and tooth, supporting a localized antagonism model.\",\n      \"evidence\": \"Immunohistochemistry and in situ hybridization across kidney development/injury and incisor primordia with apoptosis assays\",\n      \"pmids\": [\"17943079\", \"17555714\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Colocalization does not prove direct local antagonism\", \"Apoptotic mechanism downstream of BMP not fully mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved the dual-pathway logic by demonstrating SOSTDC1 inhibits LRP5/6-dependent Wnt signaling in tooth development, with reciprocal genetic epistasis.\",\n      \"evidence\": \"Wise-null mice rescued by Lrp5/Lrp6 dosage reduction, gain-of-function overexpression, and Fgf/Shh downstream readouts\",\n      \"pmids\": [\"20724449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical SOSTDC1-LRP5/6 interaction not shown here\", \"Quantitative balance between BMP and Wnt inhibition unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated ligand-selective BMP-7 antagonism and an effector (MMP-12) connecting SOSTDC1 loss to disease attenuation in the kidney.\",\n      \"evidence\": \"Recombinant SOSTDC1 selectivity assays in breast cancer cells and Col4a3/USAG-1 double-knockout Alport mice with mesangial MMP-12 assays\",\n      \"pmids\": [\"21113658\", \"20197625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural determinant of BMP-7 selectivity not defined\", \"Tubule-to-glomerulus crosstalk mechanism inferred\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirmed BMP-7 as the functional ligand in tooth development through ligand-supplementation rescue.\",\n      \"evidence\": \"BMP-7 supplementation in USAG-1 mutant incisor explants and subrenal capsule transplants with Smad/Msx1/Dlx2 readouts\",\n      \"pmids\": [\"24816837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative Wnt contribution in this context not quantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified upstream transcriptional and epigenetic control of SOSTDC1, explaining its silencing in cancer.\",\n      \"evidence\": \"E4BP4 promoter luciferase, bisulfite sequencing, shRNA and 5'-Aza-dC in breast cancer cells\",\n      \"pmids\": [\"25338303\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of E4BP4 regulation across tissues unknown\", \"Whether methylation alone or with E4BP4 dominates silencing unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended SOSTDC1 function to skin appendage and metabolic patterning, showing tissue-specific dominance of Wnt versus BMP outputs.\",\n      \"evidence\": \"Sostdc1-null mice analyzed for hair follicle/mammary placodes (Wnt) and pancreatic islet insulin secretion (BMP target genes)\",\n      \"pmids\": [\"22509524\", \"22829579\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of pathway choice per tissue not defined\", \"Direct receptor interactions not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed redundancy with Sost and a Wnt-SHH-Gli3 epistatic network governing digit patterning.\",\n      \"evidence\": \"Sost/Sostdc1 single and double knockouts with Sox9, Gli1, Gli3 expression analysis\",\n      \"pmids\": [\"23994639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link between SOSTDC1 and SHH/Gli not established\", \"Non-cell-autonomous signal mediator unidentified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established SOSTDC1 roles in bone via MSC quiescence and antagonistic interplay with RUNX2 in tooth, broadening the regulatory network.\",\n      \"evidence\": \"Sostdc1-/- fracture callus MSC quantification and Usag-1/Runx2 double-knockout tooth phenotyping\",\n      \"pmids\": [\"27102547\", \"27518316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct RUNX2-SOSTDC1 regulatory mechanism not biochemically mapped\", \"MSC-intrinsic versus niche effects not separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Characterized SOSTDC1 tumor-suppressive outputs through cell-cycle and kinase-pathway control across multiple cancers.\",\n      \"evidence\": \"Overexpression in thyroid and NSCLC cells with cyclin/p21/p27/Rb/E2F and PI3K/Akt, MAPK/Erk readouts\",\n      \"pmids\": [\"26378658\", \"27087917\", \"28551845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether effects are secreted-antagonist or intracellular not resolved\", \"Direct upstream receptor for these signals not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered cell-extrinsic immune regulation by SOSTDC1, controlling NK maturation and TFR differentiation via Wnt-\\u03b2-catenin.\",\n      \"evidence\": \"Sostdc1-/- and conditional KO mice, reciprocal bone marrow transplants, fate tracking, and WNT pathway analysis\",\n      \"pmids\": [\"30814306\", \"32820125\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating immune-cell effects not defined\", \"Whether BMP also contributes in immune contexts unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded the mechanistic repertoire to non-canonical and receptor-coupled signaling, including a direct ALCAM/CD166 interaction driving stem-cell traits.\",\n      \"evidence\": \"Co-IP/MS/confocal/competition ELISA mapping SOSTDC1-ALCAM, domain mapping, and c-Jun/JNK rescue in gastric cancer; transgenic Sertoli BMP-Smad apoptosis; myeloma-osteoblast contact-dependent co-culture\",\n      \"pmids\": [\"32801337\", \"31815038\", \"31391487\", \"30776499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How secreted-antagonist and ALCAM-receptor roles are integrated unknown\", \"Structural basis of ALCAM binding not solved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided the biophysical basis for antagonist potency by showing SOSTDC1 functions as a stable dimer within the DAN family.\",\n      \"evidence\": \"SEC-MALS, analytical ultracentrifugation, non-denaturing PAGE, and cell-based BMP/GDF5 inhibition assays comparing dimeric SOSTDC1 to monomeric SOST\",\n      \"pmids\": [\"32779697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the SOSTDC1-BMP complex absent\", \"Dimer interface residues not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated therapeutic feasibility of SOSTDC1 silencing to rescue congenital tooth agenesis.\",\n      \"evidence\": \"In vivo Usag-1 siRNA delivery via cationized gelatin and renal capsule transplantation in Runx2-KO mice\",\n      \"pmids\": [\"34211084\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Durability and off-target effects of silencing not assessed\", \"Translation to human odontogenesis untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed an unexpected intracellular, nuclear function whereby SOSTDC1 stabilizes CHD1 to promote DNA repair and chemoresistance.\",\n      \"evidence\": \"Nuclear fractionation, importin-\\u03b1-dependent translocation, SOSTDC1-CHD1 and SOSTDC1-\\u03b2-TrCP Co-IP, and HR repair/BTIC assays after Olaparib\",\n      \"pmids\": [\"38864559\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How a secreted protein accesses the nucleus mechanistically unclear\", \"Single lab; reciprocal validation of CHD1 stabilization limited\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected T-cell-derived SOSTDC1 to systemic metabolism through adipocyte LRP5/6-\\u03b2-catenin signaling.\",\n      \"evidence\": \"T cell-specific Sostdc1 KO mice under obesity challenge with adipocyte Wnt pathway and TCR-stimulation secretion assays\",\n      \"pmids\": [\"40173040\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct SOSTDC1-LRP5/6 binding in adipocytes not shown\", \"Relative role versus BMP in adipose unclear\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified a chaperone-disrupting, pro-ferroptotic activity, showing SOSTDC1 competitively binds HSPA5 to destabilize GPX4 in kidney injury.\",\n      \"evidence\": \"USAG-1 KO mice, USAG-1-HSPA5 and HSPA5-GPX4 Co-IP, truncation mutagenesis, ferroptosis/GPX4 stability assays, and human transplant biopsies\",\n      \"pmids\": [\"42177164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How extracellular antagonist activity relates to this intracellular axis unresolved\", \"Structural HSPA5-binding determinant only mapped by truncation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how SOSTDC1's distinct secreted-antagonist, receptor-coupled (ALCAM), nuclear (CHD1), and chaperone-disrupting (HSPA5) activities are spatially and functionally coordinated within a single cell.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model integrating extracellular and intracellular roles\", \"No high-resolution structure of SOSTDC1 with any partner\", \"Mechanism switching between secretion and nuclear translocation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 6, 8, 26]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 8, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 24, 25]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 6, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 6, 9, 11]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20, 25]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP7\", \"LRP5\", \"LRP6\", \"ALCAM\", \"CHD1\", \"HSPA5\", \"GPX4\", \"BTRC\"]\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}